![A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | SpringerLink A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-018-4728-6/MediaObjects/125_2018_4728_Fig1_HTML.png)
A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | SpringerLink
![Identification of Maturity-Onset-Diabetes of the Young (MODY) mutations in a country where diabetes is endemic | Scientific Reports Identification of Maturity-Onset-Diabetes of the Young (MODY) mutations in a country where diabetes is endemic | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-95552-z/MediaObjects/41598_2021_95552_Fig1_HTML.png)
Identification of Maturity-Onset-Diabetes of the Young (MODY) mutations in a country where diabetes is endemic | Scientific Reports
![The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY) | Clinical Diabetes and Endocrinology | Full Text The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY) | Clinical Diabetes and Endocrinology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40842-020-00112-5/MediaObjects/40842_2020_112_Fig1_HTML.png)